66357-35-5
MOSINTER
66357-35-5
Availability: | |
---|---|
Payment & Shipping Terms | Supply Capacity | ||
Payment Terms: | T/T, WU | Production Capacity: | 500kg/year |
Min. Order: | 1 Gram | Packing: | according to the customer's requirements |
Means of Transport: | Ocean, Air, Land | Delivery Date: | 7 days |
Ranitidine hydrochloride
CAS: 66357-35-5
Item | Index |
Molecular Formula | C13H22N4O3S |
Molecular weight | 314.4 |
Specification | CP/USP/EP |
Appearance | Off-white or light yellow crystalline powder |
Melting point | 69-70°C |
Solubility (in water) | 24.7 mg/mL |
Storage Condition | Desiccate at +4°C |
Ranitidine is a histamine H2-receptor antagonist that inhibits stomach acid production. It is commonly used in treatment of peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD). Ranitidine is also used alongside fexofenadine and other antihistamines for the treatment of skin conditions such as hives. Ranitidine is also known to give false positives for methamphetamine on drug tests.
It is on the World Health Organization's List of Essential Medicines, a list of the most important medication needed in a basic health system.
Medical use
Relief of heartburn, acid indigestion, and sour stomach.
Short-term and maintenance therapy of gastric and duodenal ulcers
Ranitidine can also be coadministered with NSAIDs to reduce the risk of ulceration. Proton-pump inhibitors (PPIs) are more effective for the prevention of NSAID-induced ulcers.
Pathologic GI Hypersecretory Conditions such as Zollinger-Ellison Syndrome
Gastroesophageal Reflux (GERD)